Cargando…

Inhibition of thrombin generation in human plasma by phospholipid transfer protein

BACKGROUND: Plasma phospholipid transfer protein (PLTP) transfers lipids between donors and acceptors (e.g., from HDL to VLDL) and modulates lipoprotein composition, size, and levels. No study has reported an assessment of the effects of PLTP on blood clotting reactions, such as reflected in thrombi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deguchi, Hiroshi, Wolfbauer, Gertrud, Cheung, Marian C., Banerjee, Yajnavalka, Elias, Darlene J., Fernández, José A., Albers, John J., Griffin, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504036/
https://www.ncbi.nlm.nih.gov/pubmed/26185485
http://dx.doi.org/10.1186/s12959-015-0054-0
_version_ 1782381413530599424
author Deguchi, Hiroshi
Wolfbauer, Gertrud
Cheung, Marian C.
Banerjee, Yajnavalka
Elias, Darlene J.
Fernández, José A.
Albers, John J.
Griffin, John H.
author_facet Deguchi, Hiroshi
Wolfbauer, Gertrud
Cheung, Marian C.
Banerjee, Yajnavalka
Elias, Darlene J.
Fernández, José A.
Albers, John J.
Griffin, John H.
author_sort Deguchi, Hiroshi
collection PubMed
description BACKGROUND: Plasma phospholipid transfer protein (PLTP) transfers lipids between donors and acceptors (e.g., from HDL to VLDL) and modulates lipoprotein composition, size, and levels. No study has reported an assessment of the effects of PLTP on blood clotting reactions, such as reflected in thrombin generation assays, or on the association of venous thrombosis (VTE) risk with PLTP activity. METHODS: The in vitro effects of PLTP on blood coagulation reactions and the correlations between plasma PLTP activity levels and VTE were studied. RESULTS: Recombinant (r) PLTP concentration-dependently inhibited plasma thrombin generation and factor XII-dependent kallikrein generation when sulfatide was used to stimulate factor XII autoactivation in plasma. However, rPLTP did not inhibit thrombin generation in plasma induced by factor XIa or tissue factor, implicating an effect of PLTP on contact activation reactions. In purified systems, rPLTP inhibited factor XII autoactivation stimulated by sulfatide in the presence of VLDL. In surface plasmon resonance studies, purified factor XII bound to immobilized rPLTP, implying that rPLTP inhibits factor XII-dependent contact activation by binding factor XII in the presence of lipoproteins. Analysis of plasmas from 40 male patients with unprovoked VTE and 40 matched controls indicated that low PLTP lipid transfer activity (≤25th percentile) was associated with an increased risk of VTE after adjustment for body mass index, plasma lipids, and two known thrombophilic genetic risk factors. CONCLUSION: These data imply that PLTP may be an antithrombotic plasma protein by inhibiting generation of prothrombotic factor XIIa in the presence of VLDL. This newly discovered anticoagulant activity of PLTP merits further clinical and biochemical studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12959-015-0054-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4504036
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45040362015-07-17 Inhibition of thrombin generation in human plasma by phospholipid transfer protein Deguchi, Hiroshi Wolfbauer, Gertrud Cheung, Marian C. Banerjee, Yajnavalka Elias, Darlene J. Fernández, José A. Albers, John J. Griffin, John H. Thromb J Original Basic Research BACKGROUND: Plasma phospholipid transfer protein (PLTP) transfers lipids between donors and acceptors (e.g., from HDL to VLDL) and modulates lipoprotein composition, size, and levels. No study has reported an assessment of the effects of PLTP on blood clotting reactions, such as reflected in thrombin generation assays, or on the association of venous thrombosis (VTE) risk with PLTP activity. METHODS: The in vitro effects of PLTP on blood coagulation reactions and the correlations between plasma PLTP activity levels and VTE were studied. RESULTS: Recombinant (r) PLTP concentration-dependently inhibited plasma thrombin generation and factor XII-dependent kallikrein generation when sulfatide was used to stimulate factor XII autoactivation in plasma. However, rPLTP did not inhibit thrombin generation in plasma induced by factor XIa or tissue factor, implicating an effect of PLTP on contact activation reactions. In purified systems, rPLTP inhibited factor XII autoactivation stimulated by sulfatide in the presence of VLDL. In surface plasmon resonance studies, purified factor XII bound to immobilized rPLTP, implying that rPLTP inhibits factor XII-dependent contact activation by binding factor XII in the presence of lipoproteins. Analysis of plasmas from 40 male patients with unprovoked VTE and 40 matched controls indicated that low PLTP lipid transfer activity (≤25th percentile) was associated with an increased risk of VTE after adjustment for body mass index, plasma lipids, and two known thrombophilic genetic risk factors. CONCLUSION: These data imply that PLTP may be an antithrombotic plasma protein by inhibiting generation of prothrombotic factor XIIa in the presence of VLDL. This newly discovered anticoagulant activity of PLTP merits further clinical and biochemical studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12959-015-0054-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-16 /pmc/articles/PMC4504036/ /pubmed/26185485 http://dx.doi.org/10.1186/s12959-015-0054-0 Text en © Deguchi et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Basic Research
Deguchi, Hiroshi
Wolfbauer, Gertrud
Cheung, Marian C.
Banerjee, Yajnavalka
Elias, Darlene J.
Fernández, José A.
Albers, John J.
Griffin, John H.
Inhibition of thrombin generation in human plasma by phospholipid transfer protein
title Inhibition of thrombin generation in human plasma by phospholipid transfer protein
title_full Inhibition of thrombin generation in human plasma by phospholipid transfer protein
title_fullStr Inhibition of thrombin generation in human plasma by phospholipid transfer protein
title_full_unstemmed Inhibition of thrombin generation in human plasma by phospholipid transfer protein
title_short Inhibition of thrombin generation in human plasma by phospholipid transfer protein
title_sort inhibition of thrombin generation in human plasma by phospholipid transfer protein
topic Original Basic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504036/
https://www.ncbi.nlm.nih.gov/pubmed/26185485
http://dx.doi.org/10.1186/s12959-015-0054-0
work_keys_str_mv AT deguchihiroshi inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT wolfbauergertrud inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT cheungmarianc inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT banerjeeyajnavalka inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT eliasdarlenej inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT fernandezjosea inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT albersjohnj inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein
AT griffinjohnh inhibitionofthrombingenerationinhumanplasmabyphospholipidtransferprotein